Literature DB >> 31041062

Statins and metformin for chemoprevention of hepatocellular carcinoma.

Jonggi Choi1, Lewis R Roberts2.   

Abstract

Entities:  

Year:  2016        PMID： 31041062      PMCID： PMC6490194          DOI： 10.1002/cld.568

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  5 in total

Review 1.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

2.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

Review 3.  Statins Show Promise Against Progression of Liver Disease.

Authors:  Prashanth Francis; Lisa M Forman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-12-20

4.  Metformin promotes susceptibility to experimental Leishmania braziliensis infection.

Authors:  Filipe Rocha Lima; Lais de Melo Ferreira; Tainá Alves Malta; Icaro Bonyek-Silva; Reinan Lima Santos; Natália Machado Tavares; Edgar Marcelino de Carvalho Filho; Sérgio Arruda
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-11-16       Impact factor: 2.743

5.  Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis.

Authors:  Shen Li; Sarani Ghoshal; Mozhdeh Sojoodi; Gunisha Arora; Ricard Masia; Derek J Erstad; Michael Lanuti; Yujin Hoshida; Thomas F Baumert; Kenneth K Tanabe; Bryan C Fuchs
Journal:  J Gastrointest Surg       Date:  2018-10-26       Impact factor: 3.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.